OrthoPediatrics (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the full-scale launch of the Pediatric Nailing Platform|FEMUR, OrthoPediatrics’ newest rigid intramedullary nailing system. The initial beta launch surgical cases, utilizing this innovative system, have received very positive surgeon feedback and have reinforced OrthoPediatrics’ confidence in the full-scale US launch of this best-in-class offering.

As quoted in the press release:

The Pediatric Nailing Platform|FEMUR system features two distinct child and adolescent implant offerings optimized for pediatric-specific anatomy. The system also includes a full suite of new instrumentation. The system’s enhanced child nail offering ranges from 7-9mm, while the new adolescent nails range from 9-12mm. In combination with the novel Carbon-Fiber targeting arm, and other high precision instruments, the PNP|FEMUR system can effectively address both trauma and deformity correction procedures alike.

Greg Odle, Executive Vice President, stated, “The early feedback on PNP|FEMUR has been tremendous!  This truly represents the first ever pediatric nailing platform the market has ever seen, and will be the foundation of our intramedullary technology going forward. It is the result of a very thoughtful and intentional development process, understanding the needs of the pediatric surgeons who treat femoral fractures and deformities. It’s another example of what OrthoPediatrics does; focusing ALL of our resources on helping children with orthopedic problems.”

Click here to read the full press release.